Weekly round-up #267
The VALIDATE PhD Showcase offers a unique opportunity for PhD students to improve their presentation skills and share their research with an international network of peers. The online event features quick-fire presentations followed by interactive workshops with senior VALIDATE Investigators. Registration is now open for the event on September 12, 2023, at 15:00 BST.
Don't miss this chance to network, collaborate, and gain valuable feedback for future presentations - www.validate-network.org/event/phd-showcase
- UKRI Future Leaders Fellowships - Establishing the careers of world-class research and innovation leaders across academia - deadline 4 July 2023
- MRC Developmental Pathway Funding Scheme - funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions - deadline 19 July 2023
- BSI Connect Immune Research Lab Placement Grants - Grants to fund researchers to undertake a formal placement at a selected laboratory to learn a new skill to carry out experiments essential to a project - deadline 22 June 2023
Find a full list of all relevant external funding on our external funding page.
Training Opportunities and Events:
- BSI Midlands Immunology Group Symposium 2023, College Court Conference Centre, Leicester, UK, 8 June 2023
- FOCIS 2023 Annual Meeting, Boston, MA, USA, FOCIS 2023 Annual Meeting, 20 - 23 June 2023
- Professor in Infectious Diseases, University of Keele UK, deadline 23 May 2023
- Senior Program Officer or Program Officer, Tuberculosis, 2021, Gates Foundation, Seattle WA, No stated deadline.
Other relevant career opportunities are on our jobs page.
- Long-acting vaccine delivery systems, Walvekar P et al, in Advanced Drug Delivery
- Central nervous system tuberculosis immunopathology is driven by matrix destruction with matrix metalloproteinases inhibition reducing inflammation and improving survival, Poh XY et al, in International Journal of Infectious Diseases
- A molecular and immunological signature of cd4 + t cells in post kala-azar dermal leishmaniasis, Kumar A et al, in International Journal of Infectious Diseases.
- Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates, Wang R et al, in Vaccine
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
TB cases continue to rise in Canada, Zendal and IAVI partner on the development of MTBVAC, and the BCG Vaccine might be protective against Alzheimer's. The Quratis' novel TB vaccine has been confirmed safe in a phase 2 study, Opera News Nigeria shared an analysis of TB reduction in the country, and the Stop TB Partnership held an engagement session called From Innovation to Implementation: Preparing now for new tools to End TB. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter..
Published: 24 May 2023